Insmed, Inc. (INSM)
124.03
-1.74
(-1.38%)
USD |
NASDAQ |
Aug 24, 16:00
124.03
0.00 (0.00%)
After-Hours: 20:00
Insmed Gross Profit Margin (Quarterly) : 83.71% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 83.71% |
| March 31, 2026 | 83.82% |
| December 31, 2025 | 82.51% |
| September 30, 2025 | 78.29% |
| June 30, 2025 | 72.69% |
| March 31, 2025 | 75.72% |
| December 31, 2024 | 73.75% |
| September 30, 2024 | 75.99% |
| June 30, 2024 | 75.40% |
| March 31, 2024 | 75.21% |
| December 31, 2023 | 76.45% |
| September 30, 2023 | 77.28% |
| June 30, 2023 | 76.88% |
| March 31, 2023 | 76.86% |
| December 31, 2022 | 75.83% |
| September 30, 2022 | 78.25% |
| June 30, 2022 | 72.93% |
| March 31, 2022 | 74.67% |
| December 31, 2021 | 74.08% |
| September 30, 2021 | 75.52% |
| June 30, 2021 | 73.33% |
| March 31, 2021 | 72.38% |
| December 31, 2020 | 70.74% |
| September 30, 2020 | 72.80% |
| June 30, 2020 | 73.65% |
| Date | Value |
|---|---|
| March 31, 2020 | 73.72% |
| December 31, 2019 | 78.22% |
| September 30, 2019 | 80.23% |
| June 30, 2019 | 79.42% |
| March 31, 2019 | 75.35% |
| December 31, 2018 | 62.66% |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 76.88% |
| United Therapeutics Corp. | 87.30% |
| ACADIA Pharmaceuticals, Inc. | 90.81% |
| Biogen, Inc. | 61.37% |
| Gilead Sciences, Inc. | 79.81% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -99.54% |
| Return on Assets | -38.79% |
| Return on Invested Capital | -53.79% |
| Profit Margin (Quarterly) | -3.11% |
| Operating Margin (Quarterly) | -23.81% |
| Return on Net Operating Assets | -144.0% |